vimarsana.com

Polypharmacology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Moffitt Cancer Center researchers identify hidden target of ROS1 inhibitor lorlatinib

Targeted cancer drugs are widely used because of their ability to inhibit specific proteins involved in cancer development with fewer side effects compared to chemotherapy drugs.

Danielle ellisUwe rixDepartment of defense lung cancer research programDepartment of drug discovery at moffittNational cancer instituteMoffitt lung cancer centerMoffitt cancer centerMoffitt cancer center foundationCell chemical biologyDrug discoveryDefense lung cancer research programLung cancerNon small cell lung cancerSmall cell lung cancer

Researchers analyze potential of niclosamide as a SARS-CoV-2 treatment

A recent study posted to the bioRxiv preprint server assessed whether niclosamide could be employed in coronavirus disease 2019 (COVID-19) therapy.

Coronavirus disease covid 19Ars cov 2Covid 19N vitroEvere acute respiratoryEvere acute respiratory syndromeSpike protein

How Two Undergraduate Scientists Uncovered One of the Pharmaceutical Industries Biggest Secrets

How Two Undergraduate Scientists Uncovered One of the Pharmaceutical Industries Biggest Secrets
forbes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forbes.com Daily Mail and Mail on Sunday newspapers.

Ann palladinoKristenm johnChristopherj giulianoAlexanderr chaitClara tuckerJasonm sheltzerDevona lukowZacharyc galluzzoErinl sausvilleChris giulianoConnor abramowiczLuwei liuAnn linJason sheltzerGenetics at stanford universityCold spring harbor laboratory

vimarsana © 2020. All Rights Reserved.